Related Experiment Video
Updated: Aug 12, 2026

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)
Published on: February 21, 2011
Slowing down ALS--is this good or bad?
1Department of Neurology, New England Medical Center, Boston, MA 02111, USA.
Abstract:
The availability of a drug that provides modest relief in ALS without altering its inevitable progression and end, has posed new ethical and economic problems for patients, caregivers and physicians. Early evidence suggests that riluzole does provide a short additional quality of life and economic benefit for patient and society. However, there is a clear need for additional therapies, even if the benefit is minor.
More Related Videos
07:20A Novel Approach to Overcome Movement Artifact When Using a Laser Speckle Contrast Imaging System for Alternating Speeds of Blood Microcirculation
Published on: August 30, 2017
09:27Eye Movements in Visual Duration Perception: Disentangling Stimulus from Time in Predecisional Processes
Published on: January 19, 2024
Related Concept Videos
Types of Damping
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with bradycardia...
Downsampling
The Fourier transform of the decimated sequence reveals a combination of scaled and shifted versions of the original spectrum. This...
Upsampling
Decreasing Function
Introduction to Limits